|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.270 SEK | 0.00% |
|
+0.95% | -35.53% |
| Jul. 08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| Jun. 30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +0.95% | +5.83% | -17.43% | -35.53% | -61.22% | -84.12% | -98.02% | - | 19.47M | |
| +0.86% | +1.43% | -1.00% | +35.30% | +11.29% | +47.17% | +163.68% | +391.77% | +1,356.97% | 1,067B | |
| +1.59% | +4.09% | +3.43% | +15.78% | +27.28% | +56.51% | +52.50% | +53.26% | +110.47% | 635B | |
| +0.95% | +1.91% | +2.37% | +30.52% | +13.51% | +36.30% | +82.78% | +120.19% | +302.42% | 458B | |
| +0.72% | +7.72% | +5.46% | +11.24% | +8.87% | +37.11% | +31.14% | +3.70% | +43.32% | 347B | |
| +0.65% | +3.67% | +1.13% | +11.87% | +16.44% | +36.73% | +40.63% | +53.24% | +55.82% | 295B | |
| +1.26% | +3.63% | -10.27% | -8.17% | -6.96% | +18.91% | +19.91% | +55.46% | +173.56% | 262B | |
| +1.12% | -1.11% | +3.00% | +23.09% | -0.28% | -28.11% | -39.05% | +15.39% | +71.70% | 216B | |
| +1.22% | +2.66% | +4.94% | +9.14% | +14.89% | +22.66% | +59.87% | +53.44% | +124.27% | 203B | |
| -1.18% | -3.70% | +1.12% | -0.84% | +5.35% | +11.28% | +67.52% | +88.09% | +59.54% | 161B | |
| -1.88% | -2.04% | +1.03% | -9.11% | -1.45% | -1.01% | -34.05% | -41.31% | -33.37% | 140B | |
| +0.94% | +2.22% | +7.95% | +5.76% | +15.11% | +28.21% | -2.08% | -8.27% | -17.28% | 127B | |
| +0.90% | -1.71% | -2.85% | +10.94% | +5.29% | +1.64% | +35.65% | +139.96% | +402.59% | 121B | |
| +0.71% | -0.39% | +1.47% | -2.90% | -7.39% | -10.40% | -21.63% | -12.06% | -0.12% | 104B | |
| +1.02% | +3.11% | -1.97% | -3.75% | +6.36% | +38.81% | +38.05% | +10.95% | -8.49% | 102B | |
| -7.66% | -7.42% | -9.59% | -8.02% | -16.92% | -7.82% | +67.07% | +64.62% | +422.75% | 74.54B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +2.14% | +3.85% | +11.46% | +10.56% | +19.32% | +34.01% | +31.08% | +56.05% | +26.85% | 55.09B | |
| -2.66% | +0.49% | +9.82% | -4.64% | -10.27% | -5.23% | +11.17% | -9.74% | +235.70% | 52.08B | |
| +1.32% | -1.20% | +1.54% | +21.78% | +26.29% | +61.42% | -10.60% | -7.35% | -50.60% | 51.52B | |
| Average | +0.11% | +0.24% | +1.84% | +6.90% | +4.80% | +16.68% | +26.82% | +48.91% | +182.01% | 226.71B | |
| Weighted average by Cap. | +0.68% | +1.47% | +1.08% | +16.68% | +10.81% | +31.88% | +66.23% | +130.54% | +417.61% |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
